Focus on adequate antimicrobial treatment and de-escalation in the ICU.

about

Focus on adequate antimicrobial treatment and de-escalation in the ICU.

Item

http://www.wikidata.org/entity/Q48328989

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Focus on adequate antimicrobial treatment and de-escalation in the ICU.

@en

Focus on adequate antimicrobial treatment and de-escalation in the ICU.

@nl

type

Item

label

Focus on adequate antimicrobial treatment and de-escalation in the ICU.

@en

Focus on adequate antimicrobial treatment and de-escalation in the ICU.

@nl

prefLabel

Focus on adequate antimicrobial treatment and de-escalation in the ICU.

@en

Focus on adequate antimicrobial treatment and de-escalation in the ICU.

@nl

P1476

Focus on adequate antimicrobial treatment and de-escalation in the ICU.

@en

P2093

Gordon Doig

http://www.w3.org/2001/XMLSchema#string

Jean-Francois Timsit

http://www.w3.org/2001/XMLSchema#string

P2860

Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis.

Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing.

Duration of colonization with antimicrobial-resistant bacteria after ICU discharge.

Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.

Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Ten tips on how to win the war against resistance to antibiotics.

Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration.

Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial.

What's new in antimicrobial use and resistance in critically ill patients?

De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial.

P2888

s00134-016-4566-2

P304

1856-1858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1007/S00134-016-4566-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

D D Benoit

P577

2016-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27686358

http://www.w3.org/2001/XMLSchema#string